- 全部删除
您的购物车当前为空
JI-101 (CGI-1842) 是一种有口服活性的多靶点激酶抑制剂,能够抑制VEGFR2,PDGFRβ和EphB4,具有抗癌作用。


为众多的药物研发团队赋能,
让新药发现更简单!
JI-101 (CGI-1842) 是一种有口服活性的多靶点激酶抑制剂,能够抑制VEGFR2,PDGFRβ和EphB4,具有抗癌作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 315 | In stock | |
| 5 mg | ¥ 745 | In stock | |
| 10 mg | ¥ 1,190 | In stock | |
| 25 mg | ¥ 2,360 | In stock | |
| 50 mg | ¥ 3,650 | In stock | |
| 100 mg | ¥ 5,180 | In stock | |
| 200 mg | ¥ 7,130 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 763 | In stock |
JI-101 相关产品
| 产品描述 | JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4). |
| 别名 | JI 101, CGI-1842 |
| 分子量 | 466.33 |
| 分子式 | C22H20BrN5O2 |
| CAS No. | 900573-88-8 |
| Smiles | COc1ccc(Br)cc1NC(=O)Nc1cccc2n(Cc3ccnc(N)c3)ccc12 |
| 密度 | 1.50 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 27.5 mg/mL (58.97 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容